<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00192868</url>
  </required_header>
  <id_info>
    <org_study_id>DEDICATION</org_study_id>
    <nct_id>NCT00192868</nct_id>
  </id_info>
  <brief_title>Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction</brief_title>
  <official_title>Drug Elution and DIstal Protection During Percutaneous CoronAry Intervention in sT Elevation Myocardial InfarctiON. Acronym: Dedication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical, echocardiographic and angiographic
      outcome of distal protection in the infarct related coronary artery and implantation of drug
      eluting versus bare metal stents in patients with ST-elevation myocardial infarctions treated
      acutely with percutaneous coronary intervention.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2005</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ST segment resolution</measure>
    <time_frame>90 min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Late loss (difference between minimal lumen diameter in stented segment immediately after and at 8 month follow up).</measure>
    <time_frame>immediately after and at 8 month follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Restenosis</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximal elevations in blood concentrations of CK-MB enzyme and troponin-T</measure>
    <time_frame>Post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wall motion index</measure>
    <time_frame>During hospitalisation: day 3-5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal lumen diameter</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of binary restenosis (&gt;50% diameter stenosis), diameter stenosis (%) in the stented segment.</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of stent thrombosis and MACE.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Distal protection and drug eluting stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute onset typical chest pain of &lt; 12 hours' duration

          -  ST-elevation of &gt; 4 mm (1mm = 0.1 mV) in contiguous leads of the electrocardiogram

          -  High grade stenosis or occlusion of a native major coronary artery that can be crossed
             with a soft or intermediate tip guidewire

          -  Possibility to perform distal protection of the infarct-related artery

        Exclusion Criteria:

          -  History of previous myocardial infarction

          -  Use of fibrinolytic agents for the index infarction

          -  Left main stenosis

          -  Heavily calcification of abdominal aorta or occlusive iliofemoral disease hampering
             access to the coronary ostias by the femoral route

          -  Known renal failure

          -  Other significant cardiac disease

          -  Other severe disease with an expected survival &lt; 1 year

          -  Known allergy against clopidogrel or contrast media that can not be avoided/limited by
             medication

          -  Linguistic difficulties needing an interpreter

          -  Gastrointestinal bleeding within 1 month

          -  Childbearing potential or pregnancy

          -  Participation in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Kelbaek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiac Cath Lab, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>September 22, 2009</last_update_submitted>
  <last_update_submitted_qc>September 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2009</last_update_posted>
  <keyword>primary PCI</keyword>
  <keyword>distal protection</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

